For instance, NCR-ILC-3, which coproduce IL-17A and IL-22, have been shown to be pathogenic in mouse models of IBD in a microbiota-dependent fashion and are increased in patients with IBD (73, 74). Here, IL17A is linked to inflammatory bowel disease.